Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2022 Results - Earnings Call Transcript

Cytosorbents Corporation (NASDAQ:NASDAQ:CTSO) Q1 2022 Earnings Conference Call May 03, 2022 04:30 PM ET Company Participants Terri Anne Powers - Vice President, Investor Relations &...

Related Keywords

United Kingdom ,London ,City Of ,Germany ,Hamburg ,United States ,New Jersey ,Boston ,Massachusetts ,Ireland ,Canada ,Russia ,Ukraine ,American ,German ,Priya Sachdeva ,Jiny Kim ,Cytosorbents Europe ,Asklepios Kliniken Gmb ,Shaun Whittemore ,Kathy Bloch ,Makis Deliargyris ,Christian Steiner ,Chris Cramer ,Phillip Chan ,Justin Walsh ,Christopher Cramer ,Josh Jennings ,Efthymios Deliargyris ,Vincent Capponi ,Kathleen Bloch ,Terri Anne ,Frank Pinal ,Zach Weiner ,Danielle Antalffy ,Company Participants ,Cytosorbents Corp ,Data Solutions At Zimmer Biomet ,Smart Implants Technology ,European Society Of Cardiology ,University Of Athens Germany ,International Symposium Of Intensive Care ,Health Management ,Cytosorbents Corporation ,American Association Of Thoracic Surgery ,Asklepios Group ,European Union Notified Body ,Corporate Communications ,Stanford Byers Center ,Business Development ,Investor Relations Corporate Communications ,Conference Call May ,Anne Powers ,Investor Relations ,Chief Operating ,Vice President ,Managing Director ,First Quarter ,Terri Anne Powers ,Chief Executive Officer ,Chief Operating Officer ,Chief Financial Officer ,Chief Medical Officer ,Executive Vice President ,Safe Harbor ,Private Securities Litigation Reform Act ,Data Safety Monitoring Board ,Data Solutions ,Zimmer Biomet ,Country Manager ,Asklepios Kliniken ,Georg Asklepios Hospital ,Emergency Use Authorization ,International Symposium ,Intensive Care ,Emergency Medicine ,European Society ,American Association ,Thoracic Surgery ,Accelerated Medicare Coverage ,Innovative Technologies Impact ,Patient Access ,Health Management Policy ,